170856-37-8Relevant articles and documents
Discovery of N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N′-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a potent and selective anaplastic lymphoma kinase (ALK) inhibitor
Iikubo, Kazuhiko,Kondoh, Yutaka,Shimada, Itsuro,Matsuya, Takahiro,Mori, Kenichi,Ueno, Yoko,Okada, Minoru
, p. 251 - 262 (2018/03/13)
Anaplastic lymphoma kinase (ALK) is a validated therapeutic target for treating echinoderm microtubule- associated protein-like 4 (EML4)-ALK positive non-small cell lung cancer (NSCLC). We synthesized a series of 1,3,5-triazine derivatives and identified ASP3026 (14a) as a potent and selective ALK inhibitor. In mice xenografted with NCI-H2228 cells expressing EML4-ALK, once-daily oral administration of 14a demonstrated dose-dependent antitumor activity. Here, syntheses and structure-activity relationship (SAR) studies of 1,3,5-triazine derivatives are described.
Syntheses of Some Alkyl, Cycloalkyl and Aryl 3-Aminophenyl Sulfones
Courtin, Alfred
, p. 1849 - 1853 (2007/10/02)
Syntheses of alkyl (1a-1i, 1m), cycloalkyl (1j, 1k) and aryl (1l) 3-aminophenyl sulfones were achieved by ethanolic Bechamp-reduction of the appropriate 3-nitrophenyl sulfones (3a-3m).The alkyl (3a-3i) and cycloalkyl (3j, 3k) 3-nitrophenyl sulfones were p